Abate, N. (2000). Obesity and cardiovascular disease. Pathogenetic role of the metabolic syndrome and therapeutic implications. J Diabetes Complications, 14(3), 154-174.
Abdelmalek, M. F., & Diehl, A. M. (2007). Nonalcoholic fatty liver disease as a complication of insulin resistance. Med Clin North Am, 91(6), 1125-1149, ix.
Ackerman, G. E., MacDonald, P. C., Gudelsky, G., Mendelson, C. R., & Simpson, E.
R. (1981). Potentiation of epinephrine-induced lipolysis by catechol estrogens and their methoxy derivatives. Endocrinology, 109(6), 2084-2088.
Adlercreutz, H., Hamalainen, E., Gorbach, S., & Goldin, B. (1992). Dietary phyto-oestrogens and the menopause in Japan. Lancet, 339(8803), 1233.
Adlercreutz, H., Markkanen, H., & Watanabe, S. (1993). Plasma concentrations of phyto-oestrogens in Japanese men. Lancet, 342(8881), 1209-1210.
Ae Park, S., Choi, M. S., Cho, S. Y., Seo, J. S., Jung, U. J., Kim, M. J., et al. (2006).
Genistein and daidzein modulate hepatic glucose and lipid regulating enzyme activities in C57BL/KsJ-db/db mice. Life Sci, 79(12), 1207-1213.
Akagiri, S., Naito, Y., Ichikawa, H., Mizushima, K., Takagi, T., Handa, O., et al.
(2008). A Mouse Model of Metabolic Syndrome; Increase in Visceral Adipose Tissue Precedes the Development of Fatty Liver and Insulin Resistance in High-Fat Diet-Fed Male KK/Ta Mice. J Clin Biochem Nutr, 42(2), 150-157.
Akahoshi, A., Goto, Y., Murao, K., Miyazaki, T., Yamasaki, M., Nonaka, M., et al.
(2002). Conjugated linoleic acid reduces body fats and cytokine levels of mice.
Biosci Biotechnol Biochem, 66(4), 916-920.
Akimoto, K., Kitagawa, Y., Akamatsu, T., Hirose, N., Sugano, M., Shimizu, S., et al.
(1993). Protective effects of sesamin against liver damage caused by alcohol or carbon tetrachloride in rodents. Ann Nutr Metab, 37(4), 218-224.
Alberti, K. G., Zimmet, P., & Shaw, J. (2005). The metabolic syndrome--a new worldwide definition. Lancet, 366(9491), 1059-1062.
Alberti, K. G., & Zimmet, P. Z. (1998). Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation. Diabet Med, 15(7), 539-553.
Anderson, J. W., Johnstone, B. M., & Cook-Newell, M. E. (1995). Meta-analysis of the effects of soy protein intake on serum lipids. N Engl J Med, 333(5), 276-282.
Aoyama, T., Peters, J. M., Iritani, N., Nakajima, T., Furihata, K., Hashimoto, T., et al.
(1998). Altered constitutive expression of fatty acid-metabolizing enzymes in
mice lacking the peroxisome proliferator-activated receptor alpha (PPARalpha). J Biol Chem, 273(10), 5678-5684.
Arita, Y., Kihara, S., Ouchi, N., Takahashi, M., Maeda, K., Miyagawa, J., et al. (1999).
Paradoxical decrease of an adipose-specific protein, adiponectin, in obesity.
Biochem Biophys Res Commun, 257(1), 79-83.
Ashakumary, L., Rouyer, I., Takahashi, Y., Ide, T., Fukuda, N., Aoyama, T., et al.
(1999). Sesamin, a sesame lignan, is a potent inducer of hepatic fatty acid oxidation in the rat. Metabolism, 48(10), 1303-1313.
Beltowski, J. (2003). Adiponectin and resistin--new hormones of white adipose tissue.
Med Sci Monit, 9(2), RA55-61.
Blaschke, F., Takata, Y., Caglayan, E., Law, R. E., & Hsueh, W. A. (2006). Obesity, peroxisome proliferator-activated receptor, and atherosclerosis in type 2 diabetes. Arterioscler Thromb Vasc Biol, 26(1), 28-40.
Boue, S. M., Wiese, T. E., Nehls, S., Burow, M. E., Elliott, S., Carter-Wientjes, C. H., et al. (2003). Evaluation of the estrogenic effects of legume extracts
containing phytoestrogens. J Agric Food Chem, 51(8), 2193-2199.
Bourassa, P. A., Milos, P. M., Gaynor, B. J., Breslow, J. L., & Aiello, R. J. (1996).
Estrogen reduces atherosclerotic lesion development in apolipoprotein E-deficient mice. Proc Natl Acad Sci U S A, 93(19), 10022-10027.
Brown, S. A., Hutchinson, R., Morrisett, J., Boerwinkle, E., Davis, C. E., Gotto, A. M., Jr., et al. (1993). Plasma lipid, lipoprotein cholesterol, and apoprotein
distributions in selected US communities. The Atherosclerosis Risk in Communities (ARIC) Study. Arterioscler Thromb, 13(8), 1139-1158.
Browning, J. D., & Horton, J. D. (2004). Molecular mediators of hepatic steatosis and liver injury. J Clin Invest, 114(2), 147-152.
Bruschi, F., Meschia, M., Soma, M., Perotti, D., Paoletti, R., & Crosignani, P. G.
(1996). Lipoprotein(a) and other lipids after oophorectomy and estrogen replacement therapy. Obstet Gynecol, 88(6), 950-954.
Carr, M. C. (2003). The emergence of the metabolic syndrome with menopause. J Clin Endocrinol Metab, 88(6), 2404-2411.
Carreau, C., Flouriot, G., Bennetau-Pelissero, C., & Potier, M. (2008). Enterodiol and enterolactone, two major diet-derived polyphenol metabolites have different impact on ERalpha transcriptional activation in human breast cancer cells. J Steroid Biochem Mol Biol, 110(1-2), 176-185.
Cederroth, C. R., Vinciguerra, M., Kuhne, F., Madani, R., Doerge, D. R., Visser, T. J., et al. (2007). A phytoestrogen-rich diet increases energy expenditure and decreases adiposity in mice. Environ Health Perspect, 115(10), 1467-1473.
Chang, W. C., Yu, Y. M., Wu, C. H., Tseng, Y. H., & Wu, K. Y. (2005). Reduction of
oxidative stress and atherosclerosis in hyperlipidemic rabbits by Dioscorea rhizome. Can J Physiol Pharmacol, 83(5), 423-430.
Charlton, M. (2004). Nonalcoholic fatty liver disease: a review of current understanding and future impact. Clin Gastroenterol Hepatol, 2(12), 1048-1058.
Chen, P. R., Tsai, C. E., Chang, H., Liu, T. L., & Lee, C. C. (2005). Sesamol induces nitric oxide release from human umbilical vein endothelial cells. Lipids, 40(9), 955-961.
Chen, S. W., Zhang, H. M., Zhang, L. S., Feng, X. F., & Peng, X. (2006). [Effects of soy isoflavone on gene expression of adiponectin in insulin-resistance rats induced by high-fat and high-sugar diet]. Wei Sheng Yan Jiu, 35(1), 46-49.
Cheng, W. Y., Kuo, Y. H., & Huang, C. J. (2007). Isolation and identification of novel estrogenic compounds in yam tuber (Dioscorea alata Cv. Tainung No. 2). J Agric Food Chem, 55(18), 7350-7358.
Chiba, H., Uehara, M., Wu, J., Wang, X., Masuyama, R., Suzuki, K., et al. (2003).
Hesperidin, a citrus flavonoid, inhibits bone loss and decreases serum and hepatic lipids in ovariectomized mice. J Nutr, 133(6), 1892-1897.
Chinetti, G., Gbaguidi, F. G., Griglio, S., Mallat, Z., Antonucci, M., Poulain, P., et al.
(2000). CLA-1/SR-BI is expressed in atherosclerotic lesion macrophages and regulated by activators of peroxisome proliferator-activated receptors.
Circulation, 101(20), 2411-2417.
Chinetti, G., Lestavel, S., Bocher, V., Remaley, A. T., Neve, B., Torra, I. P., et al.
(2001). PPAR-alpha and PPAR-gamma activators induce cholesterol removal from human macrophage foam cells through stimulation of the ABCA1 pathway. Nat Med, 7(1), 53-58.
Choi, I., Kim, Y., Park, Y., Seog, H., & Choi, H. (2007). Anti-obesity activities of fermented soygerm isoflavones by Bifidobacterium breve. Biofactors, 29(2-3), 105-112.
Choudhury, J., & Sanyal, A. J. (2004). Insulin resistance and the pathogenesis of nonalcoholic fatty liver disease. Clin Liver Dis, 8(3), 575-594, ix.
Combs, T. P., Berg, A. H., Rajala, M. W., Klebanov, S., Iyengar, P., Jimenez-Chillaron, J. C., et al. (2003). Sexual differentiation, pregnancy, calorie restriction, and aging affect the adipocyte-specific secretory protein adiponectin. Diabetes, 52(2), 268-276.
Cooke, P. S., & Naaz, A. (2004). Role of estrogens in adipocyte development and function. Exp Biol Med (Maywood), 229(11), 1127-1135.
Cortez-Pinto, H., Camilo, M. E., Baptista, A., De Oliveira, A. G., & De Moura, M. C.
(1999). Non-alcoholic fatty liver: another feature of the metabolic syndrome?
Clin Nutr, 18(6), 353-358.
Coulman, K. D., Liu, Z., Hum, W. Q., Michaelides, J., & Thompson, L. U. (2005).
Whole sesame seed is as rich a source of mammalian lignan precursors as whole flaxseed. Nutr Cancer, 52(2), 156-165.
Crawford, S. E., & Borensztajn, J. (1999). Plasma clearance and liver uptake of chylomicron remnants generated by hepatic lipase lipolysis: evidence for a lactoferrin-sensitive and apolipoprotein E-independent pathway. J Lipid Res, 40(5), 797-805.
Cruz, M. N., Luksha, L., Logman, H., Poston, L., Agewall, S., & Kublickiene, K.
(2006). Acute responses to phytoestrogens in small arteries from men with coronary heart disease. Am J Physiol Heart Circ Physiol, 290(5), H1969-1975.
Curtiss, L. K., & Boisvert, W. A. (2000). Apolipoprotein E and atherosclerosis. Curr Opin Lipidol, 11(3), 243-251.
Dang, Z., & Lowik, C. W. (2004). The balance between concurrent activation of ERs and PPARs determines daidzein-induced osteogenesis and adipogenesis. J Bone Miner Res, 19(5), 853-861.
Dang, Z. C., Audinot, V., Papapoulos, S. E., Boutin, J. A., & Lowik, C. W. (2003).
Peroxisome proliferator-activated receptor gamma (PPARgamma ) as a molecular target for the soy phytoestrogen genistein. J Biol Chem, 278(2), 962-967.
Dang, Z. C., van Bezooijen, R. L., Karperien, M., Papapoulos, S. E., & Lowik, C. W.
(2002). Exposure of KS483 cells to estrogen enhances osteogenesis and inhibits adipogenesis. J Bone Miner Res, 17(3), 394-405.
Declercq, V., Yeganeh, B., Moshtaghi-Kashanian, G. R., Khademi, H., Bahadori, B.,
& Moghadasian, M. H. (2005). Paradoxical effects of fenofibrate and nicotinic acid in apo E-deficient mice. J Cardiovasc Pharmacol, 46(1), 18-24.
Ducimetiere, P., Richard, J., & Cambien, F. (1986). The pattern of subcutaneous fat distribution in middle-aged men and the risk of coronary heart disease: the Paris Prospective Study. Int J Obes, 10(3), 229-240.
Elhage, R., Arnal, J. F., Pieraggi, M. T., Duverger, N., Fievet, C., Faye, J. C., et al.
(1997). 17 beta-estradiol prevents fatty streak formation in apolipoprotein E-deficient mice. Arterioscler Thromb Vasc Biol, 17(11), 2679-2684.
Enmark, E., & Gustafsson, J. A. (1999). Oestrogen receptors - an overview. J Intern Med, 246(2), 133-138.
Fantuzzi, G. (2005). Adipose tissue, adipokines, and inflammation. J Allergy Clin Immunol, 115(5), 911-919; quiz 920.
Farooqi, I. S., Matarese, G., Lord, G. M., Keogh, J. M., Lawrence, E., Agwu, C., et al.
(2002). Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and
neuroendocrine/metabolic dysfunction of human congenital leptin deficiency.
J Clin Invest, 110(8), 1093-1103.
Friedman, J. M., & Halaas, J. L. (1998). Leptin and the regulation of body weight in mammals. Nature, 395(6704), 763-770.
Fu, T., Kashireddy, P., & Borensztajn, J. (2003). The
peroxisome-proliferator-activated receptor alpha agonist ciprofibrate severely aggravates hypercholesterolaemia and accelerates the development of
atherosclerosis in mice lacking apolipoprotein E. Biochem J, 373(Pt 3), 941-947.
Fukumitsu, S., Aida, K., Ueno, N., Ozawa, S., Takahashi, Y., & Kobori, M. (2008).
Flaxseed lignan attenuates high-fat diet-induced fat accumulation and induces adiponectin expression in mice. Br J Nutr, 1-8.
Gervois, P., Kleemann, R., Pilon, A., Percevault, F., Koenig, W., Staels, B., et al.
(2004). Global suppression of IL-6-induced acute phase response gene expression after chronic in vivo treatment with the peroxisome
proliferator-activated receptor-alpha activator fenofibrate. J Biol Chem, 279(16), 16154-16160.
Ginsberg, H. N. (2000). Insulin resistance and cardiovascular disease. J Clin Invest, 106(4), 453-458.
Glass, C. K., & Witztum, J. L. (2001). Atherosclerosis. the road ahead. Cell, 104(4), 503-516.
Gomori, A., Ishihara, A., Ito, M., Matsushita, H., Mashiko, S., Iwaasa, H., et al.
(2007). Blockade of MCH1 receptor signalling ameliorates obesity and related hepatic steatosis in ovariectomized mice. Br J Pharmacol, 151(6), 900-908.
Grundy, S. M. (1998). Hypertriglyceridemia, atherogenic dyslipidemia, and the metabolic syndrome. Am J Cardiol, 81(4A), 18B-25B.
Grundy, S. M. (1999). Hypertriglyceridemia, insulin resistance, and the metabolic syndrome. Am J Cardiol, 83(9B), 25F-29F.
Guerre-Millo, M., Gervois, P., Raspe, E., Madsen, L., Poulain, P., Derudas, B., et al.
(2000). Peroxisome proliferator-activated receptor alpha activators improve insulin sensitivity and reduce adiposity. J Biol Chem, 275(22), 16638-16642.
Guzik, T. J., Mangalat, D., & Korbut, R. (2006). Adipocytokines - novel link between inflammation and vascular function? J Physiol Pharmacol, 57(4), 505-528.
Haffner, S. M., Stern, M. P., Mitchell, B. D., Hazuda, H. P., & Patterson, J. K. (1990).
Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity, and body-fat distribution. Diabetes, 39(3), 283-288.
Hallund, J., Ravn-Haren, G., Bugel, S., Tholstrup, T., & Tetens, I. (2006). A lignan
complex isolated from flaxseed does not affect plasma lipid concentrations or antioxidant capacity in healthy postmenopausal women. J Nutr, 136(1), 112-116.
Hallund, J., Tetens, I., Bugel, S., Tholstrup, T., Ferrari, M., Teerlink, T., et al. (2006).
Daily consumption for six weeks of a lignan complex isolated from flaxseed does not affect endothelial function in healthy postmenopausal women. J Nutr, 136(9), 2314-2318.
Hamosh, M., & Hamosh, P. (1975). The effect of estrogen on the lipoprotein lipase activity of rat adipose tissue. J Clin Invest, 55(5), 1132-1135.
Harding, M., Cowan, S., Hole, D., Cassidy, L., Kitchener, H., Davis, J., et al. (1990).
Estrogen and progesterone receptors in ovarian cancer. Cancer, 65(3), 486-491.
Harmon, A. W., & Harp, J. B. (2001). Differential effects of flavonoids on 3T3-L1 adipogenesis and lipolysis. Am J Physiol Cell Physiol, 280(4), C807-813.
Heine, P. A., Taylor, J. A., Iwamoto, G. A., Lubahn, D. B., & Cooke, P. S. (2000).
Increased adipose tissue in male and female estrogen receptor-alpha knockout mice. Proc Natl Acad Sci U S A, 97(23), 12729-12734.
Hirata, F., Fujita, K., Ishikura, Y., Hosoda, K., Ishikawa, T., & Nakamura, H. (1996).
Hypocholesterolemic effect of sesame lignan in humans. Atherosclerosis, 122(1), 135-136.
Hirose, N., Inoue, T., Nishihara, K., Sugano, M., Akimoto, K., Shimizu, S., et al.
(1991). Inhibition of cholesterol absorption and synthesis in rats by sesamin. J Lipid Res, 32(4), 629-638.
Hong, M., Lin, M. Y., Huang, J. M., Baumeister, P., Hakre, S., Roy, A. L., et al. (2005).
Transcriptional regulation of the Grp78 promoter by endoplasmic reticulum stress: role of TFII-I and its tyrosine phosphorylation. J Biol Chem, 280(17), 16821-16828.
Horton, J. D., Goldstein, J. L., & Brown, M. S. (2002). SREBPs: activators of the complete program of cholesterol and fatty acid synthesis in the liver. J Clin Invest, 109(9), 1125-1131.
Hotamisligil, G. S. (2003). Inflammatory pathways and insulin action. Int J Obes Relat Metab Disord, 27 Suppl 3, S53-55.
Hu, E., Liang, P., & Spiegelman, B. M. (1996). AdipoQ is a novel adipose-specific gene dysregulated in obesity. J Biol Chem, 271(18), 10697-10703.
Hui, D. Y., Innerarity, T. L., & Mahley, R. W. (1981). Lipoprotein binding to canine hepatic membranes. Metabolically distinct apo-E and apo-B,E receptors. J.
Biol. Chem., 256(11), 5646-5655.
Hwang, J., Hodis, H. N., & Sevanian, A. (2001). Soy and alfalfa phytoestrogen
extracts become potent low-density lipoprotein antioxidants in the presence of acerola cherry extract. J Agric Food Chem, 49(1), 308-314.
Ide, T., Ashakumary, L., Takahashi, Y., Kushiro, M., Fukuda, N., & Sugano, M.
(2001). Sesamin, a sesame lignan, decreases fatty acid synthesis in rat liver accompanying the down-regulation of sterol regulatory element binding protein-1. Biochim Biophys Acta, 1534(1), 1-13.
Im, J. A., Kim, S. H., Lee, J. W., Shim, J. Y., Lee, H. R., & Lee, D. C. (2006).
Association between hypoadiponectinemia and cardiovascular risk factors in nonobese healthy adults. Metabolism, 55(11), 1546-1550.
Iwu, M. M., Okunji, C. O., Ohiaeri, G. O., Akah, P., Corley, D., & Tempesta, M. S.
(1990). Hypoglycaemic activity of dioscoretine from tubers of Dioscorea dumetorum in normal and alloxan diabetic rabbits. Planta Med, 56(3), 264-267.
Jawien, J., Nastalek, P., & Korbut, R. (2004). Mouse models of experimental atherosclerosis. J Physiol Pharmacol, 55(3), 503-517.
Jeng, K. C., Hou, R. C., Wang, J. C., & Ping, L. I. (2005). Sesamin inhibits lipopolysaccharide-induced cytokine production by suppression of p38 mitogen-activated protein kinase and nuclear factor-kappaB. Immunol Lett, 97(1), 101-106.
Jeong, S., Han, M., Lee, H., Kim, M., Kim, J., Nicol, C. J., et al. (2004). Effects of fenofibrate on high-fat diet-induced body weight gain and adiposity in female C57BL/6J mice. Metabolism, 53(10), 1284-1289.
Joseph, L., Mayo, M., & FACOG. (1999). A Natural Approach to Menopause.
APPLIED NUTRITIONAL SCIENCE REPORTS, 5(7), 1-8.
Jurimae, J., & Jurimae, T. (2007). Plasma adiponectin concentration in healthy pre- and postmenopausal women: relationship with body composition, bone mineral, and metabolic variables. Am J Physiol Endocrinol Metab, 293(1), E42-47.
Juvet, L. K., Andresen, S. M., Schuster, G. U., Dalen, K. T., Tobin, K. A., Hollung, K., et al. (2003). On the role of liver X receptors in lipid accumulation in
adipocytes. Mol Endocrinol, 17(2), 172-182.
Kamal-Eldin, A., Pettersson, D., & Appelqvist, L. A. (1995). Sesamin (a compound from sesame oil) increases tocopherol levels in rats fed ad libitum. Lipids, 30(6), 499-505.
Kannel, W. B., Cupples, L. A., Ramaswami, R., Stokes, J., 3rd, Kreger, B. E., &
Higgins, M. (1991). Regional obesity and risk of cardiovascular disease; the Framingham Study. J Clin Epidemiol, 44(2), 183-190.
Kershaw, E. E., & Flier, J. S. (2004). Adipose tissue as an endocrine organ. J Clin
Endocrinol Metab, 89(6), 2548-2556.
Kim, H., Haluzik, M., Asghar, Z., Yau, D., Joseph, J. W., Fernandez, A. M., et al.
(2003). Peroxisome proliferator-activated receptor-alpha agonist treatment in a transgenic model of type 2 diabetes reverses the lipotoxic state and improves glucose homeostasis. Diabetes, 52(7), 1770-1778.
Kim, H. K., Nelson-Dooley, C., Della-Fera, M. A., Yang, J. Y., Zhang, W., Duan, J., et al. (2006). Genistein decreases food intake, body weight, and fat pad weight and causes adipose tissue apoptosis in ovariectomized female mice. J Nutr, 136(2), 409-414.
Kim, S., Shin, H. J., Kim, S. Y., Kim, J. H., Lee, Y. S., Kim, D. H., et al. (2004).
Genistein enhances expression of genes involved in fatty acid catabolism through activation of PPARalpha. Mol Cell Endocrinol, 220(1-2), 51-58.
Kita, S., Matsumura, Y., Morimoto, S., Akimoto, K., Furuya, M., Oka, N., et al.
(1995). Antihypertensive effect of sesamin. II. Protection against two-kidney, one-clip renal hypertension and cardiovascular hypertrophy. Biol Pharm Bull, 18(9), 1283-1285.
Kleemann, R., Gervois, P. P., Verschuren, L., Staels, B., Princen, H. M., & Kooistra, T.
(2003). Fibrates down-regulate IL-1-stimulated C-reactive protein gene expression in hepatocytes by reducing nuclear p50-NFkappa B-C/EBP-beta complex formation. Blood, 101(2), 545-551.
Kovanen, P. T., & Pentikainen, M. O. (2003). Pharmacological evidence for a role of liver X receptors in atheroprotection. FEBS Lett, 536(1-3), 3-5.
Kreijkamp-Kaspers, S., Kok, L., Grobbee, D. E., de Haan, E. H., Aleman, A., Lampe, J. W., et al. (2004). Effect of soy protein containing isoflavones on cognitive function, bone mineral density, and plasma lipids in postmenopausal women: a randomized controlled trial. JAMA, 292(1), 65-74.
Kubota, N., Terauchi, Y., Miki, H., Tamemoto, H., Yamauchi, T., Komeda, K., et al.
(1999). PPAR gamma mediates high-fat diet-induced adipocyte hypertrophy and insulin resistance. Mol Cell, 4(4), 597-609.
Kuiper, G. G., Lemmen, J. G., Carlsson, B., Corton, J. C., Safe, S. H., van der Saag, P.
T., et al. (1998). Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor beta. Endocrinology, 139(10), 4252-4263.
Kushiro, M., Takahashi, Y., & Ide, T. (2004). Species differences in the physiological activity of dietary lignan (sesamin and episesamin) in affecting hepatic fatty acid metabolism. Br J Nutr, 91(3), 377-386.
Laffitte, B. A., Chao, L. C., Li, J., Walczak, R., Hummasti, S., Joseph, S. B., et al.
(2003). Activation of liver X receptor improves glucose tolerance through coordinate regulation of glucose metabolism in liver and adipose tissue. Proc
Natl Acad Sci U S A, 100(9), 5419-5424.
Landau, I. T., & Zucker, I. (1976). Estrogenic regulation of body weight in the female rat. Horm Behav, 7(1), 29-39.
Lapidus, L., Bengtsson, C., Larsson, B., Pennert, K., Rybo, E., & Sjostrom, L. (1984).
Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden. Br Med J (Clin Res Ed), 289(6454), 1257-1261.
Larsson, B., Svardsudd, K., Welin, L., Wilhelmsen, L., Bjorntorp, P., & Tibblin, G.
(1984). Abdominal adipose tissue distribution, obesity, and risk of
cardiovascular disease and death: 13 year follow up of participants in the study of men born in 1913. Br Med J (Clin Res Ed), 288(6428), 1401-1404.
Latruffe, N., & Vamecq, J. (1997). Peroxisome proliferators and peroxisome proliferator activated receptors (PPARs) as regulators of lipid metabolism.
Biochimie, 79(2-3), 81-94.
Lea-Currie, Y. R., Monroe, D., & McIntosh, M. K. (1999). Dehydroepiandrosterone and related steroids alter 3T3-L1 preadipocyte proliferation and differentiation.
Comp Biochem Physiol C Pharmacol Toxicol Endocrinol, 123(1), 17-25.
Lee, C. C., Chen, P. R., Lin, S., Tsai, S. C., Wang, B. W., Chen, W. W., et al. (2004).
Sesamin induces nitric oxide and decreases endothelin-1 production in HUVECs: possible implications for its antihypertensive effect. J Hypertens, 22(12), 2329-2338.
Lee, J. S. (2006). Effects of soy protein and genistein on blood glucose, antioxidant enzyme activities, and lipid profile in streptozotocin-induced diabetic rats. Life Sci, 79(16), 1578-1584.
Lee, Y. M., Choi, J. S., Kim, M. H., Jung, M. H., Lee, Y. S., & Song, J. (2006). Effects of dietary genistein on hepatic lipid metabolism and mitochondrial function in mice fed high-fat diets. Nutrition, 22(9), 956-964.
Li, A. C., & Glass, C. K. (2004). PPAR- and LXR-dependent pathways controlling lipid metabolism and the development of atherosclerosis. J Lipid Res, 45(12), 2161-2173.
Liang, Y. Q., Akishita, M., Kim, S., Ako, J., Hashimoto, M., Iijima, K., et al. (2002).
Estrogen receptor beta is involved in the anorectic action of estrogen. Int J Obes Relat Metab Disord, 26(8), 1103-1109.
Libby, P. (2002). Inflammation in atherosclerosis. Nature, 420(6917), 868-874.
Libby, P., Ridker, P. M., & Maseri, A. (2002). Inflammation and atherosclerosis.
Circulation, 105(9), 1135-1143.
Lillioja, S., Mott, D. M., Spraul, M., Ferraro, R., Foley, J. E., Ravussin, E., et al.
(1993). Insulin resistance and insulin secretory dysfunction as precursors of
non-insulin-dependent diabetes mellitus. Prospective studies of Pima Indians.
N Engl J Med, 329(27), 1988-1992.
Lindenfeld, J., Ghali, J. K., Krause-Steinrauf, H. J., Khan, S., Adams, K., Goldman, S., et al. (2003). Hormone replacement therapy is associated with improved
survival in women with advanced heart failure. J Am Coll Cardiol, 42(7), 1238-1245.
Lindheim, S. R., Buchanan, T. A., Duffy, D. M., Vijod, M. A., Kojima, T., Stanczyk, F.
Z., et al. (1994). Comparison of estimates of insulin sensitivity in pre- and postmenopausal women using the insulin tolerance test and the frequently sampled intravenous glucose tolerance test. J Soc Gynecol Investig, 1(2), 150-154.
Liu, M. S., Jirik, F. R., LeBoeuf, R. C., Henderson, H., Castellani, L. W., Lusis, A. J., et al. (1994). Alteration of lipid profiles in plasma of transgenic mice
expressing human lipoprotein lipase. J Biol Chem, 269(15), 11417-11424.
Liu, Z., Saarinen, N. M., & Thompson, L. U. (2006). Sesamin is one of the major precursors of mammalian lignans in sesame seed (Sesamum indicum) as observed in vitro and in rats. J Nutr, 136(4), 906-912.
Makela, S., Savolainen, H., Aavik, E., Myllarniemi, M., Strauss, L., Taskinen, E., et al.
(1999). Differentiation between vasculoprotective and uterotrophic effects of ligands with different binding affinities to estrogen receptors alpha and beta.
Proc Natl Acad Sci U S A, 96(12), 7077-7082.
Marchesini, G., Brizi, M., Bianchi, G., Tomassetti, S., Bugianesi, E., Lenzi, M., et al.
(2001). Nonalcoholic fatty liver disease: a feature of the metabolic syndrome.
Diabetes, 50(8), 1844-1850.
Marchesini, G., Bugianesi, E., Forlani, G., Cerrelli, F., Lenzi, M., Manini, R., et al.
(2003). Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
Hepatology, 37(4), 917-923.
Marx, N., Sukhova, G. K., Collins, T., Libby, P., & Plutzky, J. (1999). PPARalpha activators inhibit cytokine-induced vascular cell adhesion molecule-1 expression in human endothelial cells. Circulation, 99(24), 3125-3131.
Matsumura, Y., Kita, S., Morimoto, S., Akimoto, K., Furuya, M., Oka, N., et al.
(1995). Antihypertensive effect of sesamin. I. Protection against
deoxycorticosterone acetate-salt-induced hypertension and cardiovascular hypertrophy. Biol Pharm Bull, 18(7), 1016-1019.
McCullough, A. J. (2004). The clinical features, diagnosis and natural history of nonalcoholic fatty liver disease. Clin Liver Dis, 8(3), 521-533, viii.
McElroy, J. F., & Wade, G. N. (1987). Short- and long-term effects of ovariectomy on food intake, body weight, carcass composition, and brown adipose tissue in
rats. Physiol Behav, 39(3), 361-365.
Meli, R., Pacilio, M., Raso, G. M., Esposito, E., Coppola, A., Nasti, A., et al. (2004).
Estrogen and raloxifene modulate leptin and its receptor in hypothalamus and adipose tissue from ovariectomized rats. Endocrinology, 145(7), 3115-3121.
Messina, M. J. (2002). Soy foods and soybean isoflavones and menopausal health.
Nutr Clin Care, 5(6), 272-282.
Miksicek, R. J. (1994). Interaction of naturally occurring nonsteroidal estrogens with expressed recombinant human estrogen receptor. J Steroid Biochem Mol Biol, 49(2-3), 153-160.
Miyatani, Y., Yasui, T., Uemura, H., Yamada, M., Matsuzaki, T., Kuwahara, A., et al.
(2008). Associations of circulating adiponectin with estradiol and monocyte chemotactic protein-1 in postmenopausal women. Menopause, 15(3), 536-541.
Mohamed, M. K., & Abdel-Rahman, A. A. (2000). Effect of long-term ovariectomy and estrogen replacement on the expression of estrogen receptor gene in female rats. Eur J Endocrinol, 142(3), 307-314.
Moon, K. W., Leem, J. M., Bae, S. S., Lee, K. M., Kim, S. H., Chae, H. B., et al.
(2004). [The prevalence of metabolic syndrome in patients with nonalcoholic fatty liver disease]. Korean J Hepatol, 10(3), 197-206.
Morifuji, M., Sanbongi, C., & Sugiura, K. (2006). Dietary soya protein intake and exercise training have an additive effect on skeletal muscle fatty acid oxidation enzyme activities and mRNA levels in rats. Br J Nutr, 96(3), 469-475.
Mueller, S. O., Simon, S., Chae, K., Metzler, M., & Korach, K. S. (2004).
Phytoestrogens and their human metabolites show distinct agonistic and antagonistic properties on estrogen receptor alpha (ERalpha) and ERbeta in human cells. Toxicol Sci, 80(1), 14-25.
Naaz, A., Yellayi, S., Zakroczymski, M. A., Bunick, D., Doerge, D. R., Lubahn, D. B., et al. (2003). The soy isoflavone genistein decreases adipose deposition in mice. Endocrinology, 144(8), 3315-3320.
Nakai, M., Harada, M., Nakahara, K., Akimoto, K., Shibata, H., Miki, W., et al.
(2003). Novel antioxidative metabolites in rat liver with ingested sesamin. J Agric Food Chem, 51(6), 1666-1670.
Nakano, D., Itoh, C., Takaoka, M., Kiso, Y., Tanaka, T., & Matsumura, Y. (2002).
Antihypertensive effect of sesamin. IV. Inhibition of vascular superoxide production by sesamin. Biol Pharm Bull, 25(9), 1247-1249.
Nakashima, Y., Plump, A. S., Raines, E. W., Breslow, J. L., & Ross, R. (1994).
ApoE-deficient mice develop lesions of all phases of atherosclerosis
throughout the arterial tree. Arteriosclerosis & Thrombosis, 14(1), 133-140.
Nemoto, Y., Toda, K., Ono, M., Fujikawa-Adachi, K., Saibara, T., Onishi, S., et al.
(2000). Altered expression of fatty acid-metabolizing enzymes in aromatase-deficient mice. J Clin Invest, 105(12), 1819-1825.
Noguchi, T., Ikeda, K., Sasaki, Y., Yamamoto, J., Seki, J., Yamagata, K., et al. (2001).
Effects of vitamin E and sesamin on hypertension and cerebral
thrombogenesis in stroke-prone spontaneously hypertensive rats. Hypertens Res, 24(6), 735-742.
Ogawa, H., Sasagawa, S., Murakami, T., & Yoshizumi, H. (1995). Sesame lignans modulate cholesterol metabolism in the stroke-prone spontaneously hypertensive rat. Clin Exp Pharmacol Physiol Suppl, 22(1), S310-312.
Ohta, H., Wada, H., Niwa, T., Kirii, H., Iwamoto, N., Fujii, H., et al. (2005).
Disruption of tumor necrosis factor-alpha gene diminishes the development of atherosclerosis in ApoE-deficient mice. Atherosclerosis, 180(1), 11-17.
Okamoto, Y., Kihara, S., Ouchi, N., Nishida, M., Arita, Y., Kumada, M., et al. (2002).
Adiponectin reduces atherosclerosis in apolipoprotein E-deficient mice.
Circulation, 106(22), 2767-2770.
Owen, A. J., & Abbey, M. (2004). The effect of estrogens and phytoestrogenic lignans on macrophage uptake of atherogenic lipoproteins. Biofactors, 20(3), 119-127.
Palin, S. L., McTernan, P. G., Anderson, L. A., Sturdee, D. W., Barnett, A. H., &
Palin, S. L., McTernan, P. G., Anderson, L. A., Sturdee, D. W., Barnett, A. H., &